The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse

Serotonergic Drugs for Depression and Beyond

(2013) Stephen M. Stahl et al.   CURRENT DRUG TARGETS

Ketamine for Depression: Where Do We Go from Here?

(2012) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY

Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: anin vivomicrodialysis study in mice

(2012) Hai T Nguyen et al.   BRITISH JOURNAL OF PHARMACOLOGY

Steric Hindrance Mutagenesis in the Conserved Extracellular Vestibule Impedes Allosteric Binding of Antidepressants to the Serotonin Transporter

(2012) Per Plenge et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Vasopressin V1bReceptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders

(2012) Guy Griebel et al.   JOURNAL OF CLINICAL PSYCHIATRY

Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics

(2012) M. Manning et al.   JOURNAL OF NEUROENDOCRINOLOGY

Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT

(2012) L. Descarries et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse

(2012) J. P. R. Jacobsen et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice

(2011) J P R Jacobsen et al.   MOLECULAR PSYCHIATRY

Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter

(2011) Brent J. Thompson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter—a review of current understanding of its mechanism of action

(2011) Huailing Zhong et al.   PSYCHOPHARMACOLOGY

Erratum: Agomelatine, the first melatonergic antidepressant: discovery, characterization and development

(2010) Christian de Bodinat et al.   NATURE REVIEWS DRUG DISCOVERY

Regulation of monoamine transporters: Role of transporter phosphorylation

(2010) Sammanda Ramamoorthy et al.   PHARMACOLOGY & THERAPEUTICS

Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3

(2009) Agnes Leffler et al.   BIOCHEMICAL PHARMACOLOGY

Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action

(2009) Catherine J. Harmer et al.   BRITISH JOURNAL OF PSYCHIATRY

Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons

(2009) Katharina Kittler et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: Kinetic binding studies with the ALI/VFL–SI/TT mutant

(2009) Huailing Zhong et al.   NEUROSCIENCE LETTERS

The pharmacology of sigma-1 receptors

(2009) Tangui Maurice et al.   PHARMACOLOGY & THERAPEUTICS

A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH1Antagonist) in the Treatment of Major Depression

(2008) Brendon Binneman et al.   AMERICAN JOURNAL OF PSYCHIATRY

Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice

(2008) M Kreilgaard et al.   BRITISH JOURNAL OF PHARMACOLOGY

A2A Adenosine Receptor and its Modulators: Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and Antagonists

(2008) G. Cristalli et al.   CURRENT PHARMACEUTICAL DESIGN

Differential regulation of serotonin-1A receptor-stimulated [35S]GTPγS binding in the dorsal raphe nucleus by citalopram and escitalopram

(2008) Dania V. Rossi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Further evidence for an antidepressant potential of the selective σ1 agonist SA 4503: electrophysiological, morphological and behavioural studies

(2008) Guillaume Lucas et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline

(2008) Dania V. Rossi et al.   JOURNAL OF NEUROCHEMISTRY

Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants

(2008) Katerina V. Savelieva et al.   PLoS One

Role of GSK3  in behavioral abnormalities induced by serotonin deficiency

(2008) J.-M. Beaulieu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice

(2008) Meredith A. Fox et al.   PSYCHOPHARMACOLOGY

Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan

(2008) Jacob P. R. Jacobsen et al.   PSYCHOPHARMACOLOGY

Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: a comparative and correlational study

(2008) Tomohiro Kobayashi et al.   PSYCHOPHARMACOLOGY